SUN PHARMACEUTICAL INDUSTRIES INC: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx o…
| Source | FDA · Drugs |
|---|---|
| Date | 2026-06-17 |
| Product | DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01. |
| Reason / hazard | Presence of Particulate matter: Particulate matter identified as glass. |
| Classification | Class I |
| Official notice | — |
| Record ID | fda-drug:D-0580-2026 |